SCHEMBL8925352

SCHEMBL8925352

CC(=O)NC1([C@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)CCCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 7/20 0.55
CCKAR P32238 1/20 0.55
PSEN1 P49768 7/20 0.51
PSEN2 P49810 7/20 0.51
APH1B Q8WW43 7/20 0.51
NCSTN Q92542 7/20 0.51
APH1A Q96BI3 7/20 0.51
PSENEN Q9NZ42 7/20 0.51
GABRP O00591 1/20 0.51
GABRD O14764 1/20 0.51
GABRA1 P14867 1/20 0.51
GABRB1 P18505 1/20 0.51
GABRG2 P18507 1/20 0.51
GABRB3 P28472 1/20 0.51
GABRA5 P31644 1/20 0.51
GABRA3 P34903 1/20 0.51
GABRA2 P47869 1/20 0.51
GABRB2 P47870 1/20 0.51
GABRA4 P48169 1/20 0.51
GABRE P78334 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6045163 0.72 GABRA1 (0.72) CCKBRCCKARGABRPGABRDGABRA1
SCHEMBL4701785 0.71 CCKBR (0.68) CCKBRCCKARGABRPGABRDGABRA1
SCHEMBL5803563 0.71 PSEN1 (0.69) CCKBRCCKARPSEN1PSEN2APH1B
SCHEMBL13502675 0.71 PSEN1 (0.62) CCKBRCCKARPSEN1PSEN2APH1B
SCHEMBL14497508 0.71 OPRK1 (0.72) CCKBRCCKARGABRPGABRDGABRA1
SCHEMBL7207460 0.71 CCKBR (0.78) CCKBRCCKAR
SCHEMBL2927644 0.71 CCKBR (0.78) CCKBRCCKAR
SCHEMBL8610163 0.71 CCKBR (1.00) CCKBRCCKARKCNH2
SCHEMBL7592676 0.71 CCKBR (1.00) CCKBRCCKARKCNH2
SCHEMBL9866322 0.71 CCKBR (1.00) CCKBRCCKARKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5595990-A TREATMENT OF CARDIOVASCULAR DISORDERS MERCK & CO., INC. (US) 1997-01-21 US disclosed
US-5426185-A Antiarrhythmia agents having reduced side effects MERCK & CO., INC. (US) 1995-06-20 US disclosed
WO-1995014471-A1 ANTIARRHYTHMIC BENZODIAZEPINES MERCK & CO., INC. (US) 1995-06-01 WO disclosed